Author:
Flaker Greg,Lopes Renato D.,Al-Khatib Sana M.,Hermosillo Antonio G.,Hohnloser Stefan H.,Tinga Brian,Zhu Jun,Mohan Puneet,Garcia David,Bartunek Jozef,Vinereanu Dragos,Husted Steen,Harjola Veli Pekka,Rosenqvist Marten,Alexander John H.,Granger Christopher B.
Funder
Boehringer Ingelheim
Sanofi-Aventis;
Bristol-Myers Squibb, AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo
Bristol-Myers Squibb
Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer Inc., and Bayer
Bristol-Myers Squibb, CSL Behring, Pfizer Inc., Phyxius Pharmaceuticals, and Regado Biosciences;
AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer Inc., Daiichi Sankyo, GlaxoSmithKline, the Medtronic Foundation, Merck, Sanofi-Aventis, Astellas, and The Medicines Company
Medtronic Foundation and Merck & Co., Inc.
Subject
Cardiology and Cardiovascular Medicine